Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test the safety and efficacy of study drug LY4065967 for the treatment of diabetic peripheral neuropathic pain (DPNP). This trial is part of the chronic pain master pro...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
1-317-615-4559LillyTrials@Lilly.comPhysicians interested in becoming principal investigators please contact
CONTACT
clinical_inquiry_hub@lilly.comLead Sponsor
Eli Lilly and Company
NCT07231419 · Diabetic Peripheral Neuropathic Pain
NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more
NCT06221241 · Diabetic Peripheral Neuropathic Pain
NCT07377721 · Diabetic Peripheral Neuropathic Pain
NCT05177094 · Diabetic Peripheral Neuropathic Pain
Central Research Associates
Birmingham, Alabama
Synexus Clinical Research US, Inc.
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions